Phase 1 Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cell In Patients With Oral Premalignant Lesions
NCT07631013
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Squamous Cell Carcinoma
Interventions
DRUG:
TROP2 CAR/IL-15 TGFBR2 KO NK cells
Sponsor
M.D. Anderson Cancer Center